ArticleAlimentary pharmacology & therapeutics2024

Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population.

Carolin V Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.